US Patent Issued to Halda Therapeutics OpCo on June 30 for "Heterobifunctional compounds and methods of treating disease" (Connecticut Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,599, issued on June 30, was assigned to Halda Therapeutics OpCo Inc. (New Haven, Conn.).

"Heterobifunctional compounds and methods of treating disease" was invented by Kyle J. Eastman (Killingworth, Conn.), Katherine J. Kayser-Bricker (Branford, Conn.), James John Mousseau (Salem, Conn.) and Kanak Shail Raina (Branford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides heterobifunctional compounds, pharmaceutical compositions, and their use treating disease, such as cancer."

The patent was filed on Oct. 18, 2024, under Application No. 18/920,528.

*For further information, including images, charts and tables, please visit:...